Product Details for: Blenrep
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Injection
Intravenous
100MG
Single-Dose Vial
351(a)
Blenrep
Disc
Proper Name
belantamab mafodotin-blmf
belantamab mafodotin-blmf
BLA Number
761158
761158
Applicant
GlaxoSmithKline Intellectual Property Development Ltd. England
GlaxoSmithKline Intellectual Property Development Ltd. England
Original Approval Date
August 5, 2020
August 5, 2020
Date of First Licensure